Healthcare
Life Healthcare Group Holdings Limited(LTGHF)
Live Price
Offline$0.815
+0.00% today
1Y Change
-0.49%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $17.72B
- Revenue Growth
- -94.3%
- EPS Growth
- -95.4%
- Dividend Yield
- 23.5%
Coverage: 254 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Life Healthcare Group Holdings Limited (LTGHF) is a Healthcare stock with a market cap of $17.72B and listed on OTC. The stock last traded around $0.81 and down 0.5% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of -94.3%, EPS growth of -95.4%, a dividend yield of 23.5%. What stands out right now is revenue -94.3%, EPS -95.4%, free cash flow -93.6% with operating margin -2.1% and ROIC -2.8%. The dividend matters to the case here, with a current yield around 23.5%. Valuation is more restrained than many high-expectation growth names at P/E 4.6 and price/sales 0.7. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines LTGHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-94.3% vs +7.6% peer median
Operating Margin
Below sector median
-2.1% vs +19.4% peer median
P/E
Below sector median
4.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 21, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -94.3% and EPS is at -95.4%, with operating margin around -2.1%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 23.5%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 21, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 May 20, 2025 | โ | +0.0% | +0.0% | -3.8% |
2024 Nov 26, 2024 | โ | +0.0% | +0.0% | -3.8% |
Benchmark Edge
LTGHF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LTGHF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LTGHF Max Drawdown
-16.50%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for LTGHF and SPY.
Company Overview
Life Healthcare Group Holdings Limited
Other OTC
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Canada, the United Kingdom, rest of Europe, and Internationally. It operates through two segments, Hospitals and Complementary Services; and Healthcare Services. The company provides range of acute hospitals and complementary services; Life Esidimeni services, such as chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, and primary healthcare and substance abuse recovery programs; and life employee health solutions, including on-site occupational and primary healthcare services and employee wellness programs. It also offers services in the areas of diagnostics, mental health, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedic, pediatric, dermatology, ophthalmology, gynecology, and obstetric. In addition, the company provides diagnostic imaging services; magnetic resonance imaging and computerized tomography scanners; develops, manufactures, and distributes radiopharmaceuticals for use in positron emission tomography-computerized tomography (PET-CT) diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
- Leadership
- Peter Gerard Wharton-Hood Harvard
- IPO Date
- Jul 12, 2011
- Employees
- 16.1k
- Street Address
- Oxford Parks
- Mailing
- Johannesburg, 2196
- Region
- Johannesburg, ZA
- Reporting Currency
- USD
- Investor Line
- 27 11 219 9000
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 4.6
- EV/EBITDA
- 4.7
- Price/Sales
- 0.7
- Price/Book
- 1.6
Growth
- Revenue
- -94.3%
- EPS
- -95.4%
- Free Cash Flow
- -93.6%
Profitability
- Gross Margin
- 25.6%
- Operating Margin
- -2.1%
- Net Margin
- 15.3%
- ROE
- 38.4%
- ROIC
- -2.8%
Balance Sheet
- Debt/Equity
- 0.35
- Current Ratio
- 1.20
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.